Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Antag Therapeutics presents positive Phase 1 results at the 2026 Scientific Sessions of the American Diabetes Association for AT7687, a first-in-class GIPR antagonist
GlobeNewswire, Inc.
AT7687 demonstrated a favorable safety and tolerability profile with no adverse GI tolerability signals identified Once-weekly dosing potential and demonstrated target engagement across the doses tested were confirmed Preclinical data from...
Bronstein, Gewirtz & Grossman LLC Urges POET Technologies Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire, Inc.
NEW YORK, June 07, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against POET Technologies Inc. (NASDAQ: POET) and certain of its...
JIATF 401 Validates Next-Generation Counter-Drone Technology at Yuma
DVIDS - Georgia
YUMA, Ariz.— Joint Interagency Task Force 401 (JIATF-401) recently evaluated the effectiveness of the Sky Valor system against small unmanned aerial systems (sUAS) during a visit to Marine Corps Air Station Yuma, Arizona.
Prime Minister Carney to travel to France, Ireland, and the 2026 G7 Leaders’ Summit to deepen Canada’s partnerships across trade, defence, and technology
Prime Minister of Canada
CANADA, June 6 - In a more dangerous and divided world, Canada’s government is focused on what we can control.
Her Bodhi Claims Evaluated: What Research Reveals About This Primal Queen Alternative, Weight Loss Support and Consumer Reviews
GlobeNewswire, Inc.
Editorial note: This article is an independent informational evaluation of publicly available product information.
DMR Seeks Shark Research Participants
Department of Marine Resources - Maine
The Maine Department of Marine Resources' Highly Migratory Species (HMS) Program leads the State’s monitoring efforts to inform fisheries management and conservation of sharks in the northern Gulf of Maine.
Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study
GlobeNewswire, Inc.
•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction, supporting its broader therapeutic utility in obesity and diabetes, including as a complementary therapy alongside GLP-1...
New data from Phase 2 ZUPREME-1 trial at the American Diabetes Association 2026 Scientific Sessions further support potential of petrelintide to redefine the weight management experience for people living with overweight and obesity
GlobeNewswire, Inc.
Press release – No. 13 / 2026 New data from Phase 2 ZUPREME-1 trial at the American Diabetes Association 2026 Scientific Sessions further support potential of petrelintide to redefine the weight management experience for people living with...
DBV Technologies to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
GlobeNewswire, Inc.
Châtillon, France, June 5, 2026 DBV Technologies to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT) (the “Company”), a late-stage...
Global Aerospace's SM4 Aviation Safety Program Offers Essentials on Sleep Need vs. Sleep Capacity and The Science of Sleep Banking
GlobeNewswire, Inc.
Morris Plains, NJ, June 05, 2026 (GLOBE NEWSWIRE) -- Recall the last time you were on a flight or duty that cut into your natural daily sleep pattern.
Science is HERE All Summer at The Tech Interactive
GlobeNewswire, Inc.
San Jose, CA, June 04, 2026 (GLOBE NEWSWIRE) -- Summer is HERE at The Tech Interactive, San Jose’s science center, with hands-on experiences for curious minds of all ages.
Rivus Pharmaceuticals Announces Preclinical Data for RV-8451, a Muscle-Preserving, Oral GLP-1, at ADA 2026 Scientific Sessions
GlobeNewswire, Inc.
- Preclinical NHP data demonstrate significant fat‑specific weight loss with RV‑8451, while preserving lean mass and showing no gastrointestinal adverse events - - IND‑enabling studies advancing, with IND submission for RV-8451 in obesity targeted...
HRC Technology Solutions LLC Expands Scope and Is Successfully Reappraised at CMMI® Services Maturity Level 3, Reinforcing Its AI-Driven Operating Model
GlobeNewswire, Inc.
SOUTHLAKE, Texas, June 05, 2026 (GLOBE NEWSWIRE) -- HRC Technology Solutions LLC, a leading technology-enabled Revenue Cycle Management (RCM) solutions provider to U.S. healthcare organizations, today announced that its Revenue Cycle Management...
A New Award from MSCRF to Lentigen Technology, Inc. to Commercialize Curative Approaches for Sickle Cell Disease
EIN Presswire
Developing a new gene vector, and a point-of-care manufacturing platform, hematopoietic stem cells will be engineered as a means to treat sickle cell disease GATIHERSBURG, MARYLAND, MD, UNITED STATES, June 5, 2026 /EINPresswire.com/ -- Lentigen...
Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis
GlobeNewswire, Inc.
Company announcement No. 21 / 2026 Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved...
Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved metabolic health in people living with obesity
GlobeNewswire, Inc.
News builds on previously announced positive topline results from SYNCHRONIZE-1 76-week trial, which met its primary endpoints and showed up to 16.6% weight loss with survodutide, a novel glucagon/GLP-1 dual agonist, from baseline.1 Detailed...
POET TECHNOLOGIES CLASS ACTION ALERT: POET Technologies, Inc. Investors Have Until June 29th to Contact Bragar Eagel & Squire, P.C. To Seek Lead Plaintiff Role
GlobeNewswire, Inc.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In POET To Contact Him Directly To Discuss Their Options If you purchased or acquired POET securities between April 1, 2026 and 08:57 AM ET on...
Computex 2026: AMZFAST Expands Beyond Gaming Monitors with Smart Displays, OLED Technology and 400Hz Esports Performance
GlobeNewswire, Inc.
TAIPEI, Taiwan, June 05, 2026 (GLOBE NEWSWIRE) -- At Computex 2026, AMZFAST unveiled its most ambitious display lineup to date, expanding beyond traditional gaming monitors into smart entertainment, premium OLED gaming, creator-focused displays,...
The National Black Church Initiative and the ACHDC Join Howard University in Promoting Tier 1 Research Across All HBCUs
EIN Presswire
WASHINGTON, DC, UNITED STATES, June 5, 2026 /EINPresswire.com/ -- The National Black Church Initiative (NBCI), a coalition of 150,000 African American and Latino faith communities comprising 27.7 million members, announced its support for...
Green Technology Market to Reach $84.5 Billion by 2030 with 22.3% CAGR
EIN Presswire
The Business Research Company's Green Technology Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, June 5, 2026 /EINPresswire.com/ -- "The green technology sector has been rapidly...
Sign up for:
Sci-Tech News Today
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.